Research just came out a week ago in May 2026 in the most reputable scientific research journal Nature.
It shows that a 5-in-1 molecule CORRECTS obesity and diabetes. This molecule is not radically new - it is a combination of Mounjaro/Zepbound GLP-1R/GIPR targeting with PPARa/b/y targeting.
It shows Ozempic gives ~50% fat loss in 2 weeks. This new drug gives ~75% fat loss in 2 weeks (and glucose normalization).
Pretty exciting. This is still in the preclinical stage, but it should go through all the stages quickly. So be on the watch out for it, if you like your morning donuts too much.
It shows that a 5-in-1 molecule CORRECTS obesity and diabetes. This molecule is not radically new - it is a combination of Mounjaro/Zepbound GLP-1R/GIPR targeting with PPARa/b/y targeting.
It shows Ozempic gives ~50% fat loss in 2 weeks. This new drug gives ~75% fat loss in 2 weeks (and glucose normalization).
Pretty exciting. This is still in the preclinical stage, but it should go through all the stages quickly. So be on the watch out for it, if you like your morning donuts too much.
